Bio Essence Corp
BIOE- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001723059
No open-market purchases or sales by Bio Essence Corp insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding BIOE, Q2 2026
No superinvestor reported holding BIOE at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Bio Essence Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2024 (view filing) | Oct 28-30 | 21 daysLate | Yan YinChief Executive Officer | SSale | −323.8K | $1.40 | −$454.8K | −79.8%82.1K after | 3 lots |
| Oct 11, 2024 (view filing) | Jun 6, 2023 | 493 days | Yan YinChief Executive Officer | PPurchase | +5.00M | $0.50 | +$2.50M | +55.6%14.0M after | Amended |
| Oct 10, 2024 (view filing) | Sep 25-27 | 15 daysLate | Yan YinChief Executive Officer | SSale | −90.2K | $1.13 | −$102.1K | −0.7%13.7M after | 3 lots |
| Oct 10, 2024 (view filing) | Sep 30 | 10 daysLate | Yan YinChief Executive Officer | SSale | −1.99K | $2.35 | −$4.68K | 0.0%13.7M after | |
| Oct 10, 2024 (view filing) | Jul 2-5 | 100 days | Yan YinChief Executive Officer | SSale | −224.0K | $8.62 | −$1.93M | −1.6%13.8M after | Amended3 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Bio Essence Corp at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding BIOE in 13F filings for Q2 2026.